| 7.3 |
21.8 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 6.5 |
26.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 6.4 |
19.3 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 6.4 |
19.3 |
GO:0060829 |
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 6.1 |
6.1 |
GO:0033598 |
mammary gland epithelial cell proliferation(GO:0033598) |
| 6.0 |
23.9 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 5.8 |
17.4 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 5.7 |
28.5 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 5.6 |
16.9 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 5.6 |
16.7 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 5.6 |
5.6 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 5.3 |
15.8 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 4.9 |
14.8 |
GO:0007387 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 4.7 |
28.4 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 4.7 |
14.2 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 4.7 |
14.0 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 4.6 |
27.7 |
GO:0015878 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 4.6 |
18.3 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 4.6 |
22.8 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 4.5 |
17.9 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 4.4 |
17.4 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 4.3 |
25.9 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 4.3 |
17.1 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 4.2 |
12.5 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 4.1 |
20.7 |
GO:0015862 |
uridine transport(GO:0015862) |
| 4.1 |
12.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 4.1 |
12.2 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 4.1 |
20.3 |
GO:1903613 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 4.1 |
16.2 |
GO:0000915 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 4.0 |
11.9 |
GO:0007037 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 3.9 |
11.8 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 3.8 |
3.8 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 3.8 |
23.1 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 3.8 |
11.4 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 3.8 |
11.4 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 3.8 |
11.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 3.7 |
29.7 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 3.7 |
33.1 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 3.6 |
43.3 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 3.6 |
3.6 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 3.5 |
21.3 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 3.5 |
10.6 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 3.5 |
10.6 |
GO:0060929 |
Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 3.5 |
17.6 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 3.5 |
14.0 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 3.5 |
20.9 |
GO:0061441 |
renal artery morphogenesis(GO:0061441) |
| 3.5 |
20.8 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 3.5 |
10.4 |
GO:1902823 |
negative regulation of late endosome to lysosome transport(GO:1902823) |
| 3.4 |
10.3 |
GO:0060278 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 3.4 |
3.4 |
GO:0048377 |
lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 3.4 |
10.1 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 3.3 |
10.0 |
GO:0060623 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) regulation of chromosome condensation(GO:0060623) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 3.3 |
9.9 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 3.3 |
9.8 |
GO:0021893 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 3.2 |
13.0 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 3.2 |
16.0 |
GO:0006045 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 3.2 |
38.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 3.2 |
15.9 |
GO:0034653 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 3.2 |
28.7 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 3.2 |
6.3 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 3.1 |
34.6 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 3.1 |
18.8 |
GO:0061364 |
apoptotic process involved in luteolysis(GO:0061364) |
| 3.1 |
30.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 3.1 |
12.3 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 3.1 |
9.2 |
GO:1901536 |
negative regulation of DNA demethylation(GO:1901536) |
| 3.1 |
3.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 3.1 |
12.3 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 3.1 |
12.3 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 3.0 |
12.1 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 3.0 |
9.0 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 3.0 |
8.9 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 3.0 |
8.9 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 3.0 |
11.9 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 3.0 |
14.8 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 3.0 |
8.9 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 2.9 |
5.8 |
GO:0019520 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 2.9 |
11.7 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 2.9 |
8.7 |
GO:0000921 |
septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 2.9 |
11.6 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 2.9 |
11.6 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 2.9 |
5.7 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 2.8 |
11.4 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 2.8 |
8.5 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 2.8 |
36.8 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 2.8 |
2.8 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 2.8 |
17.0 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 2.8 |
14.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 2.8 |
114.7 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 2.8 |
16.8 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 2.8 |
11.2 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 2.8 |
8.4 |
GO:0070632 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 2.8 |
8.4 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 2.8 |
11.1 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.7 |
8.2 |
GO:1901340 |
negative regulation of store-operated calcium channel activity(GO:1901340) |
| 2.7 |
2.7 |
GO:0044346 |
fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) negative regulation of fibroblast apoptotic process(GO:2000270) |
| 2.7 |
2.7 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 2.7 |
8.2 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 2.7 |
8.2 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 2.7 |
24.5 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 2.7 |
51.5 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 2.7 |
13.5 |
GO:1904566 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 2.7 |
16.2 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 2.7 |
8.1 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 2.7 |
8.1 |
GO:0098939 |
dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 2.6 |
10.6 |
GO:0072299 |
negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 2.6 |
10.4 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 2.6 |
10.3 |
GO:0001189 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 2.6 |
7.8 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 2.6 |
12.9 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 2.6 |
10.3 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 2.6 |
23.1 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 2.6 |
15.4 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 2.6 |
7.7 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 2.5 |
17.8 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 2.5 |
5.0 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 2.5 |
12.4 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 2.5 |
19.8 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 2.5 |
9.9 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 2.5 |
2.5 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 2.4 |
19.5 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 2.4 |
4.9 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 2.4 |
9.7 |
GO:0097069 |
cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 2.4 |
4.8 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 2.4 |
12.0 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.4 |
14.3 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 2.4 |
7.1 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 2.4 |
7.1 |
GO:0060931 |
sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 2.3 |
9.4 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 2.3 |
2.3 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 2.3 |
16.4 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 2.3 |
2.3 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 2.3 |
7.0 |
GO:0046081 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 2.3 |
2.3 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 2.3 |
4.7 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 2.3 |
7.0 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 2.3 |
2.3 |
GO:0031081 |
nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
| 2.3 |
9.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 2.3 |
4.6 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 2.3 |
9.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 2.3 |
43.4 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 2.3 |
4.6 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 2.3 |
11.3 |
GO:0060978 |
angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 2.3 |
4.5 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 2.3 |
6.8 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 2.2 |
26.4 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 2.2 |
8.8 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 2.2 |
6.6 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 2.2 |
6.6 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
| 2.2 |
8.8 |
GO:1905044 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 2.2 |
2.2 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 2.2 |
8.7 |
GO:0048691 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 2.2 |
6.5 |
GO:1904975 |
response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 2.2 |
10.8 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 2.2 |
10.8 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 2.2 |
6.5 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 2.2 |
8.6 |
GO:1900133 |
regulation of renin secretion into blood stream(GO:1900133) |
| 2.2 |
10.8 |
GO:1901094 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 2.1 |
10.7 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 2.1 |
8.6 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 2.1 |
85.6 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 2.1 |
4.3 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 2.1 |
8.5 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 2.1 |
6.4 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 2.1 |
8.5 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 2.1 |
8.5 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 2.1 |
16.9 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 2.1 |
8.4 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 2.1 |
25.3 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 2.1 |
29.5 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 2.1 |
10.5 |
GO:1903971 |
mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 2.1 |
14.6 |
GO:0097473 |
cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 2.1 |
6.2 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 2.1 |
2.1 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
| 2.1 |
12.4 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 2.1 |
18.7 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 2.1 |
16.5 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 2.1 |
8.2 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 2.1 |
14.4 |
GO:0009176 |
pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 2.1 |
6.2 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 2.1 |
4.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 2.1 |
8.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 2.0 |
6.1 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 2.0 |
2.0 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 2.0 |
6.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 2.0 |
4.1 |
GO:0048370 |
lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
| 2.0 |
6.1 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 2.0 |
14.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 2.0 |
6.1 |
GO:0060733 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 2.0 |
6.0 |
GO:0061534 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 2.0 |
28.2 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 2.0 |
12.1 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 2.0 |
14.1 |
GO:2000567 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 2.0 |
8.0 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 2.0 |
6.0 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 2.0 |
20.0 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 2.0 |
17.9 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 2.0 |
7.9 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 2.0 |
13.9 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 2.0 |
17.7 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 2.0 |
7.9 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 2.0 |
11.7 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 2.0 |
3.9 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 2.0 |
3.9 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 2.0 |
3.9 |
GO:0036079 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 1.9 |
5.8 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 1.9 |
5.8 |
GO:0045144 |
meiotic sister chromatid segregation(GO:0045144) |
| 1.9 |
3.9 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 1.9 |
13.5 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 1.9 |
3.8 |
GO:1903826 |
arginine transport(GO:0015809) arginine transmembrane transport(GO:1903826) |
| 1.9 |
1.9 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 1.9 |
11.4 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 1.9 |
15.2 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 1.9 |
13.3 |
GO:0060356 |
leucine import(GO:0060356) |
| 1.9 |
9.5 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 1.9 |
3.8 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 1.9 |
1.9 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 1.9 |
15.0 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.9 |
15.0 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 1.9 |
9.4 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.9 |
13.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.9 |
22.4 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 1.9 |
1.9 |
GO:0001996 |
positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
| 1.8 |
7.4 |
GO:0061290 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.8 |
7.4 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 1.8 |
7.4 |
GO:2000230 |
negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.8 |
12.9 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 1.8 |
12.9 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 1.8 |
11.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.8 |
1.8 |
GO:0071874 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 1.8 |
9.1 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 1.8 |
1.8 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.8 |
3.6 |
GO:0051795 |
positive regulation of catagen(GO:0051795) |
| 1.8 |
7.2 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 1.8 |
7.2 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 1.8 |
7.2 |
GO:0035565 |
regulation of pronephros size(GO:0035565) |
| 1.8 |
50.4 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 1.8 |
10.8 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 1.8 |
5.4 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 1.8 |
5.4 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 1.8 |
10.8 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 1.8 |
21.5 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.8 |
5.3 |
GO:1901291 |
negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 1.8 |
19.6 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 1.8 |
10.6 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.8 |
17.7 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.8 |
1.8 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.8 |
12.3 |
GO:0019075 |
virus maturation(GO:0019075) |
| 1.8 |
7.0 |
GO:0097068 |
response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 1.8 |
3.5 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 1.8 |
5.3 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 1.8 |
1.8 |
GO:0007418 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 1.7 |
5.2 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 1.7 |
19.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 1.7 |
15.7 |
GO:0009157 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 1.7 |
47.0 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 1.7 |
1.7 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 1.7 |
5.2 |
GO:0072684 |
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 1.7 |
6.9 |
GO:0061582 |
intestinal epithelial cell migration(GO:0061582) |
| 1.7 |
5.2 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 1.7 |
13.7 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 1.7 |
1.7 |
GO:0007051 |
spindle organization(GO:0007051) |
| 1.7 |
8.5 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 1.7 |
11.9 |
GO:1900264 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 1.7 |
8.5 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.7 |
3.4 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 1.7 |
1.7 |
GO:0031427 |
response to methotrexate(GO:0031427) |
| 1.7 |
8.4 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 1.7 |
5.0 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 1.7 |
1.7 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 1.7 |
20.0 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 1.7 |
10.0 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 1.7 |
5.0 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 1.7 |
10.0 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 1.7 |
1.7 |
GO:0048617 |
embryonic foregut morphogenesis(GO:0048617) |
| 1.7 |
13.3 |
GO:0045627 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 1.6 |
11.5 |
GO:0014721 |
voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
| 1.6 |
6.5 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 1.6 |
14.7 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 1.6 |
13.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) |
| 1.6 |
4.9 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 1.6 |
4.9 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 1.6 |
21.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 1.6 |
6.5 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 1.6 |
8.1 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 1.6 |
3.2 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 1.6 |
4.8 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.6 |
3.2 |
GO:0071673 |
positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 1.6 |
4.8 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 1.6 |
6.4 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 1.6 |
4.8 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 1.6 |
9.6 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 1.6 |
8.0 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 1.6 |
3.2 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 1.6 |
4.8 |
GO:0019082 |
viral protein processing(GO:0019082) nerve growth factor production(GO:0032902) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 1.6 |
33.3 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 1.6 |
11.1 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 1.6 |
50.7 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 1.6 |
3.1 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 1.6 |
4.7 |
GO:1903567 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 1.6 |
1.6 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 1.6 |
3.1 |
GO:0003285 |
septum secundum development(GO:0003285) |
| 1.6 |
4.7 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 1.6 |
6.2 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 1.6 |
7.8 |
GO:1902904 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 1.6 |
10.9 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 1.6 |
4.7 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 1.6 |
4.7 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 1.5 |
6.2 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 1.5 |
4.6 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 1.5 |
4.6 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 1.5 |
3.1 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 1.5 |
9.3 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 1.5 |
1.5 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 1.5 |
9.2 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 1.5 |
4.6 |
GO:0086098 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 1.5 |
12.2 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 1.5 |
1.5 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 1.5 |
3.0 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 1.5 |
6.0 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 1.5 |
17.9 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 1.5 |
13.4 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 1.5 |
6.0 |
GO:0015827 |
tryptophan transport(GO:0015827) |
| 1.5 |
7.4 |
GO:0033206 |
meiotic cytokinesis(GO:0033206) |
| 1.5 |
1.5 |
GO:2000302 |
positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 1.5 |
8.9 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 1.5 |
3.0 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 1.5 |
7.4 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 1.5 |
5.9 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 1.5 |
23.6 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 1.5 |
5.9 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 1.5 |
8.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.5 |
1.5 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.5 |
1.5 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) |
| 1.5 |
22.0 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.5 |
7.3 |
GO:0031126 |
snoRNA 3'-end processing(GO:0031126) |
| 1.5 |
16.0 |
GO:0018317 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.4 |
20.3 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 1.4 |
7.2 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 1.4 |
14.3 |
GO:0046398 |
UDP-glucuronate metabolic process(GO:0046398) |
| 1.4 |
4.3 |
GO:0070666 |
regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 1.4 |
5.7 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 1.4 |
8.6 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 1.4 |
4.3 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 1.4 |
5.7 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 1.4 |
8.5 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 1.4 |
11.4 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 1.4 |
4.2 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 1.4 |
4.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 1.4 |
4.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 1.4 |
1.4 |
GO:0034552 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 1.4 |
7.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.4 |
5.6 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 1.4 |
19.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 1.4 |
2.8 |
GO:0072144 |
glomerular mesangial cell development(GO:0072144) |
| 1.4 |
8.4 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.4 |
4.2 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 1.4 |
1.4 |
GO:0014855 |
striated muscle cell proliferation(GO:0014855) |
| 1.4 |
4.2 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 1.4 |
2.8 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 1.4 |
6.9 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 1.4 |
1.4 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 1.4 |
11.0 |
GO:2000860 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 1.4 |
12.4 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 1.4 |
8.2 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 1.4 |
5.5 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 1.4 |
5.5 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.4 |
21.9 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 1.4 |
12.3 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 1.4 |
6.8 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 1.3 |
4.0 |
GO:0051086 |
chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 1.3 |
32.2 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 1.3 |
4.0 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 1.3 |
10.7 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 1.3 |
1.3 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 1.3 |
4.0 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 1.3 |
1.3 |
GO:0010868 |
negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 1.3 |
17.3 |
GO:0098870 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.3 |
14.7 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.3 |
21.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 1.3 |
1.3 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 1.3 |
11.9 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 1.3 |
5.3 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.3 |
6.6 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 1.3 |
3.9 |
GO:0003249 |
cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 1.3 |
14.4 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 1.3 |
3.9 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 1.3 |
5.2 |
GO:0035669 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 1.3 |
1.3 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 1.3 |
17.0 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 1.3 |
1.3 |
GO:0003274 |
endocardial cushion fusion(GO:0003274) |
| 1.3 |
11.8 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.3 |
13.1 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 1.3 |
14.3 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 1.3 |
2.6 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 1.3 |
28.6 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.3 |
2.6 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 1.3 |
14.2 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.3 |
1.3 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 1.3 |
6.5 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 1.3 |
5.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.3 |
1.3 |
GO:0052150 |
negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 1.3 |
7.7 |
GO:0030047 |
actin modification(GO:0030047) |
| 1.3 |
5.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 1.3 |
17.8 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 1.3 |
3.8 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.3 |
8.9 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 1.3 |
2.5 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 1.3 |
1.3 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 1.3 |
5.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.3 |
11.3 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 1.3 |
1.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 1.3 |
3.8 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 1.3 |
1.3 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 1.3 |
2.5 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 1.3 |
2.5 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 1.3 |
21.3 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 1.2 |
2.5 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 1.2 |
6.2 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 1.2 |
8.7 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.2 |
5.0 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 1.2 |
13.6 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 1.2 |
2.5 |
GO:1903516 |
regulation of single strand break repair(GO:1903516) |
| 1.2 |
4.9 |
GO:0018277 |
protein deamination(GO:0018277) |
| 1.2 |
8.6 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 1.2 |
2.5 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 1.2 |
6.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.2 |
1.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 1.2 |
12.2 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 1.2 |
2.4 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 1.2 |
7.3 |
GO:0070541 |
response to platinum ion(GO:0070541) |
| 1.2 |
17.0 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 1.2 |
2.4 |
GO:0043385 |
mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 1.2 |
3.6 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 1.2 |
2.4 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 1.2 |
8.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 1.2 |
2.4 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 1.2 |
3.6 |
GO:0042040 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 1.2 |
32.6 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 1.2 |
1.2 |
GO:0030908 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 1.2 |
10.8 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 1.2 |
1.2 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 1.2 |
6.0 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 1.2 |
3.6 |
GO:1903515 |
positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 1.2 |
4.8 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 1.2 |
22.7 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 1.2 |
2.4 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 1.2 |
4.8 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 1.2 |
1.2 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 1.2 |
5.9 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 1.2 |
3.6 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.2 |
10.6 |
GO:0030242 |
pexophagy(GO:0030242) |
| 1.2 |
14.1 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 1.2 |
9.4 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) |
| 1.2 |
4.7 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 1.2 |
25.8 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 1.2 |
10.5 |
GO:0045842 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 1.2 |
3.5 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.2 |
1.2 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 1.2 |
4.7 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 1.2 |
7.0 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 1.2 |
7.0 |
GO:2001166 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 1.2 |
4.6 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 1.2 |
9.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 1.2 |
5.8 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 1.1 |
37.8 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 1.1 |
5.7 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 1.1 |
1.1 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 1.1 |
3.4 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 1.1 |
1.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 1.1 |
3.4 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 1.1 |
7.9 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.1 |
2.3 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.1 |
4.5 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 1.1 |
6.8 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 1.1 |
14.7 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 1.1 |
4.5 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 1.1 |
2.2 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 1.1 |
2.2 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 1.1 |
7.8 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 1.1 |
5.6 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 1.1 |
1.1 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 1.1 |
5.6 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 1.1 |
4.4 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 1.1 |
1.1 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 1.1 |
12.1 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 1.1 |
14.3 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 1.1 |
9.9 |
GO:1901660 |
calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 1.1 |
1.1 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 1.1 |
4.4 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
| 1.1 |
7.7 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 1.1 |
5.5 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.1 |
4.4 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 1.1 |
1.1 |
GO:0019563 |
glycerol catabolic process(GO:0019563) |
| 1.1 |
2.2 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
| 1.1 |
17.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 1.1 |
1.1 |
GO:0060956 |
cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
| 1.1 |
4.4 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 1.1 |
1.1 |
GO:1901888 |
regulation of cell junction assembly(GO:1901888) |
| 1.1 |
2.2 |
GO:0034127 |
regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 1.1 |
3.3 |
GO:0061743 |
motor learning(GO:0061743) |
| 1.1 |
1.1 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 1.1 |
3.2 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 1.1 |
1.1 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.1 |
172.5 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 1.1 |
1.1 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 1.1 |
3.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 1.1 |
5.4 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 1.1 |
17.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 1.1 |
2.1 |
GO:0060488 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.1 |
1.1 |
GO:1901631 |
positive regulation of presynaptic membrane organization(GO:1901631) |
| 1.1 |
2.1 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 1.1 |
2.1 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 1.1 |
10.7 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 1.1 |
3.2 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.1 |
3.2 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 1.1 |
15.9 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 1.1 |
52.0 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 1.1 |
5.3 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) peptidyl-glutamine modification(GO:0018199) isopeptide cross-linking(GO:0018262) |
| 1.1 |
22.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 1.1 |
21.1 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 1.1 |
3.2 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.1 |
21.1 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 1.1 |
1.1 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 1.0 |
6.3 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 1.0 |
3.1 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 1.0 |
7.3 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 1.0 |
2.1 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 1.0 |
3.1 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 1.0 |
28.1 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 1.0 |
2.1 |
GO:0021699 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 1.0 |
25.0 |
GO:1903206 |
negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 1.0 |
9.3 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 1.0 |
10.4 |
GO:0050428 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 1.0 |
9.3 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 1.0 |
17.6 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 1.0 |
8.3 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 1.0 |
3.1 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 1.0 |
2.1 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 1.0 |
6.2 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.0 |
4.1 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 1.0 |
7.2 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 1.0 |
27.5 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 1.0 |
3.0 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 1.0 |
4.1 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 1.0 |
1.0 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 1.0 |
2.0 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 1.0 |
10.1 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 1.0 |
2.0 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 1.0 |
1.0 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 1.0 |
3.0 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 1.0 |
4.0 |
GO:2001162 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 1.0 |
2.0 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 1.0 |
4.9 |
GO:0001554 |
luteolysis(GO:0001554) |
| 1.0 |
2.0 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 1.0 |
5.9 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 1.0 |
6.9 |
GO:1902739 |
interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 1.0 |
14.8 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 1.0 |
12.8 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.0 |
3.9 |
GO:0046512 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 1.0 |
10.8 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 1.0 |
19.7 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 1.0 |
11.8 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 1.0 |
2.9 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 1.0 |
9.8 |
GO:0043090 |
amino acid import(GO:0043090) |
| 1.0 |
2.0 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) |
| 1.0 |
2.9 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 1.0 |
18.4 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 1.0 |
7.7 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.0 |
5.8 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 1.0 |
3.9 |
GO:0009224 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 1.0 |
29.9 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 1.0 |
1.0 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 1.0 |
1.0 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 1.0 |
14.4 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 1.0 |
10.5 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 1.0 |
20.1 |
GO:0014870 |
response to muscle inactivity(GO:0014870) |
| 1.0 |
2.9 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 1.0 |
3.8 |
GO:1903382 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.9 |
14.2 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.9 |
0.9 |
GO:0032886 |
regulation of microtubule-based process(GO:0032886) |
| 0.9 |
2.8 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.9 |
7.5 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.9 |
2.8 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.9 |
2.8 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.9 |
2.8 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.9 |
0.9 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.9 |
2.8 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.9 |
0.9 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.9 |
4.7 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.9 |
9.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.9 |
30.6 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.9 |
1.8 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.9 |
4.6 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.9 |
6.5 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.9 |
9.2 |
GO:1904851 |
regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.9 |
10.1 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.9 |
2.8 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.9 |
19.3 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.9 |
20.1 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.9 |
2.7 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.9 |
3.6 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.9 |
10.0 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.9 |
8.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.9 |
0.9 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.9 |
15.4 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.9 |
0.9 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.9 |
13.6 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.9 |
2.7 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.9 |
4.5 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.9 |
2.7 |
GO:0008589 |
regulation of smoothened signaling pathway(GO:0008589) |
| 0.9 |
1.8 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.9 |
4.5 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.9 |
9.8 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.9 |
7.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.9 |
8.9 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.9 |
0.9 |
GO:0060920 |
cardiac pacemaker cell differentiation(GO:0060920) |
| 0.9 |
1.8 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.9 |
5.3 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.9 |
1.8 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.9 |
3.5 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.9 |
13.2 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.9 |
3.5 |
GO:0010710 |
regulation of collagen catabolic process(GO:0010710) |
| 0.9 |
2.6 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.9 |
2.6 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.9 |
3.5 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.9 |
0.9 |
GO:2000169 |
regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.9 |
3.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.9 |
2.6 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.9 |
1.7 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.9 |
3.5 |
GO:0050732 |
negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.9 |
4.3 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.9 |
0.9 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.9 |
6.9 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.9 |
1.7 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.9 |
3.5 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.9 |
2.6 |
GO:0015822 |
mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.9 |
2.6 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.9 |
9.5 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.9 |
6.9 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.9 |
2.6 |
GO:0035572 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.9 |
6.0 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.9 |
2.6 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.9 |
6.8 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.9 |
6.0 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.8 |
0.8 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.8 |
9.3 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.8 |
6.8 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.8 |
0.8 |
GO:0042376 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.8 |
0.8 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.8 |
8.4 |
GO:0042996 |
regulation of Golgi to plasma membrane protein transport(GO:0042996) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.8 |
7.6 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.8 |
4.2 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.8 |
2.5 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.8 |
35.3 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.8 |
2.5 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.8 |
2.5 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.8 |
6.7 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.8 |
24.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.8 |
3.3 |
GO:1903803 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.8 |
4.2 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.8 |
6.7 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.8 |
3.3 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.8 |
1.7 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.8 |
4.2 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.8 |
0.8 |
GO:0072166 |
posterior mesonephric tubule development(GO:0072166) |
| 0.8 |
15.7 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.8 |
5.8 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.8 |
1.7 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.8 |
0.8 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.8 |
2.5 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.8 |
8.3 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.8 |
23.8 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.8 |
4.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.8 |
2.5 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.8 |
11.4 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.8 |
4.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.8 |
3.3 |
GO:0031455 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.8 |
2.4 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.8 |
8.9 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.8 |
7.3 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.8 |
4.9 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
| 0.8 |
8.1 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.8 |
2.4 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.8 |
3.2 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.8 |
2.4 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.8 |
8.1 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.8 |
39.3 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.8 |
3.2 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.8 |
13.5 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.8 |
10.4 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.8 |
8.0 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.8 |
3.2 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.8 |
2.4 |
GO:0009744 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.8 |
0.8 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.8 |
3.2 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.8 |
4.8 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.8 |
15.1 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.8 |
6.3 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.8 |
0.8 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.8 |
0.8 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.8 |
0.8 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.8 |
2.4 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.8 |
3.1 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.8 |
0.8 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.8 |
5.5 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.8 |
1.6 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.8 |
1.6 |
GO:0071586 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.8 |
3.9 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.8 |
11.7 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.8 |
11.7 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.8 |
13.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.8 |
4.7 |
GO:2001295 |
malonyl-CoA metabolic process(GO:2001293) malonyl-CoA biosynthetic process(GO:2001295) |
| 0.8 |
2.3 |
GO:0001993 |
regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
| 0.8 |
3.1 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.8 |
0.8 |
GO:0010827 |
regulation of glucose transport(GO:0010827) |
| 0.8 |
2.3 |
GO:2001112 |
negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.8 |
10.8 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.8 |
1.5 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.8 |
2.3 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.8 |
5.4 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.8 |
3.1 |
GO:0090579 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.8 |
23.0 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.8 |
4.6 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.8 |
6.9 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.8 |
4.5 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.8 |
4.5 |
GO:0035992 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.8 |
0.8 |
GO:1902616 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.8 |
3.0 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) |
| 0.8 |
4.5 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.8 |
20.3 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.8 |
3.0 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.8 |
7.5 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.8 |
3.8 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.8 |
3.0 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.7 |
0.7 |
GO:0034724 |
DNA replication-independent nucleosome organization(GO:0034724) |
| 0.7 |
7.5 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.7 |
6.7 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.7 |
1.5 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.7 |
13.4 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.7 |
4.4 |
GO:1902460 |
transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.7 |
3.0 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.7 |
8.9 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.7 |
7.4 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.7 |
4.4 |
GO:1901569 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.7 |
5.2 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.7 |
9.5 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.7 |
15.4 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.7 |
11.0 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.7 |
7.3 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.7 |
4.4 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.7 |
5.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.7 |
2.9 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.7 |
8.7 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.7 |
0.7 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.7 |
14.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.7 |
8.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.7 |
3.6 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.7 |
9.4 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
| 0.7 |
2.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.7 |
0.7 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.7 |
2.2 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.7 |
1.4 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.7 |
2.2 |
GO:1904098 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.7 |
2.9 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.7 |
20.8 |
GO:0072663 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.7 |
2.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.7 |
26.4 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.7 |
5.0 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.7 |
0.7 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.7 |
5.7 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.7 |
3.5 |
GO:0002155 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.7 |
0.7 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.7 |
2.1 |
GO:0019401 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.7 |
30.2 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.7 |
0.7 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.7 |
6.3 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.7 |
7.7 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.7 |
3.5 |
GO:0003343 |
proepicardium development(GO:0003342) septum transversum development(GO:0003343) cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.7 |
4.1 |
GO:1901858 |
regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.7 |
5.5 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.7 |
6.2 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.7 |
1.4 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.7 |
4.8 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.7 |
0.7 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.7 |
6.1 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.7 |
2.0 |
GO:0098780 |
response to mitochondrial depolarisation(GO:0098780) |
| 0.7 |
0.7 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.7 |
20.4 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.7 |
8.1 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.7 |
3.4 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.7 |
6.1 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.7 |
0.7 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.7 |
2.7 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.7 |
3.4 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.7 |
1.3 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.7 |
16.9 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.7 |
32.4 |
GO:0051983 |
regulation of chromosome segregation(GO:0051983) |
| 0.7 |
9.4 |
GO:0070072 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.7 |
2.7 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.7 |
1.3 |
GO:0043634 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.7 |
4.7 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.7 |
3.3 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.7 |
1.3 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.7 |
2.0 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.7 |
8.0 |
GO:0014732 |
skeletal muscle atrophy(GO:0014732) |
| 0.7 |
8.6 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.7 |
1.3 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.7 |
2.6 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.7 |
3.3 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
| 0.7 |
2.0 |
GO:0035750 |
protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.7 |
17.8 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.7 |
3.9 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.7 |
2.0 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.7 |
3.3 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.7 |
0.7 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.7 |
10.4 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.7 |
7.2 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.7 |
7.8 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.6 |
1.9 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.6 |
1.9 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.6 |
22.0 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.6 |
14.8 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.6 |
1.3 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.6 |
3.9 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.6 |
7.0 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.6 |
1.3 |
GO:0036166 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.6 |
2.5 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.6 |
3.2 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.6 |
4.4 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.6 |
1.9 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.6 |
1.3 |
GO:0009240 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.6 |
9.5 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.6 |
0.6 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.6 |
1.9 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.6 |
0.6 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.6 |
5.6 |
GO:0017182 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.6 |
5.0 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.6 |
7.5 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.6 |
4.3 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.6 |
0.6 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.6 |
3.1 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.6 |
1.8 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.6 |
1.8 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.6 |
0.6 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.6 |
1.2 |
GO:0032304 |
negative regulation of icosanoid secretion(GO:0032304) |
| 0.6 |
7.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.6 |
2.5 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.6 |
0.6 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.6 |
1.2 |
GO:0014056 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
| 0.6 |
2.4 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.6 |
2.4 |
GO:0003072 |
regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.6 |
1.8 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.6 |
1.8 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.6 |
3.6 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.6 |
3.0 |
GO:0046149 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.6 |
4.8 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.6 |
3.0 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.6 |
12.0 |
GO:0045634 |
regulation of melanocyte differentiation(GO:0045634) |
| 0.6 |
2.4 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.6 |
9.0 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.6 |
1.2 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.6 |
2.4 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.6 |
0.6 |
GO:0010544 |
negative regulation of platelet activation(GO:0010544) |
| 0.6 |
1.2 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.6 |
1.2 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.6 |
1.2 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.6 |
9.4 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.6 |
0.6 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.6 |
5.9 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.6 |
6.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.6 |
2.3 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.6 |
2.9 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.6 |
0.6 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.6 |
1.2 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.6 |
10.5 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.6 |
8.8 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.6 |
1.8 |
GO:0000959 |
mitochondrial RNA metabolic process(GO:0000959) |
| 0.6 |
2.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.6 |
1.2 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.6 |
9.3 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.6 |
4.6 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.6 |
1.7 |
GO:0061461 |
lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.6 |
2.3 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.6 |
1.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.6 |
2.3 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.6 |
7.4 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.6 |
7.4 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.6 |
0.6 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) |
| 0.6 |
1.7 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
| 0.6 |
1.1 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.6 |
1.1 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.6 |
2.3 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.6 |
1.7 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.6 |
1.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.6 |
1.1 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.6 |
1.7 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.6 |
8.4 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.6 |
1.7 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.6 |
3.3 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.6 |
1.7 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.6 |
6.7 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.6 |
9.4 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.6 |
0.6 |
GO:0098935 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.5 |
2.7 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.5 |
3.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.5 |
2.2 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.5 |
17.5 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.5 |
1.1 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.5 |
4.9 |
GO:0019049 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.5 |
3.3 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.5 |
2.7 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.5 |
2.7 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.5 |
6.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.5 |
1.6 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.5 |
22.6 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.5 |
1.1 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.5 |
5.9 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.5 |
6.4 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.5 |
2.7 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.5 |
11.7 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.5 |
1.6 |
GO:0046022 |
positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.5 |
8.0 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.5 |
2.1 |
GO:0052651 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.5 |
1.6 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.5 |
3.2 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.5 |
12.1 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.5 |
3.7 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.5 |
2.6 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.5 |
0.5 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.5 |
12.1 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.5 |
1.6 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.5 |
4.2 |
GO:1903433 |
regulation of constitutive secretory pathway(GO:1903433) |
| 0.5 |
2.1 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.5 |
20.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.5 |
1.6 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.5 |
4.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.5 |
1.6 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.5 |
1.0 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.5 |
2.6 |
GO:0048104 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.5 |
2.6 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.5 |
16.5 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.5 |
3.1 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.5 |
2.6 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.5 |
1.0 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.5 |
9.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.5 |
5.0 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.5 |
1.5 |
GO:0030806 |
negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.5 |
2.0 |
GO:0070640 |
vitamin D3 metabolic process(GO:0070640) |
| 0.5 |
8.0 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.5 |
4.5 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.5 |
7.5 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.5 |
6.5 |
GO:0050961 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.5 |
1.5 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.5 |
1.5 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.5 |
3.0 |
GO:2000234 |
regulation of ribosome biogenesis(GO:0090069) positive regulation of ribosome biogenesis(GO:0090070) regulation of rRNA processing(GO:2000232) positive regulation of rRNA processing(GO:2000234) |
| 0.5 |
1.0 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.5 |
1.5 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.5 |
0.5 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.5 |
2.0 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.5 |
1.5 |
GO:1903286 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.5 |
1.0 |
GO:1902004 |
positive regulation of beta-amyloid formation(GO:1902004) |
| 0.5 |
2.5 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.5 |
0.5 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.5 |
7.9 |
GO:0006664 |
glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
| 0.5 |
3.0 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.5 |
2.0 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.5 |
0.5 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.5 |
2.9 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.5 |
2.9 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.5 |
4.4 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.5 |
2.0 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.5 |
2.0 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.5 |
22.9 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.5 |
9.7 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.5 |
1.5 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.5 |
1.9 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.5 |
6.3 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.5 |
1.9 |
GO:0050992 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.5 |
1.9 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.5 |
5.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.5 |
1.9 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.5 |
1.0 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.5 |
1.4 |
GO:0046379 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.5 |
1.4 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.5 |
6.2 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.5 |
0.5 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.5 |
0.5 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.5 |
2.4 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 0.5 |
4.7 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.5 |
1.4 |
GO:0015820 |
leucine transport(GO:0015820) |
| 0.5 |
1.9 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.5 |
1.9 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.5 |
9.4 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.5 |
1.4 |
GO:1990874 |
regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.5 |
0.9 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.5 |
1.9 |
GO:0042144 |
vacuole fusion, non-autophagic(GO:0042144) |
| 0.5 |
0.9 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.5 |
0.5 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.5 |
0.5 |
GO:1902186 |
regulation of viral release from host cell(GO:1902186) negative regulation of viral release from host cell(GO:1902187) |
| 0.5 |
0.9 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.5 |
3.3 |
GO:0042983 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.5 |
0.9 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.5 |
5.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.5 |
1.9 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.5 |
8.8 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.5 |
5.5 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.5 |
5.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.5 |
1.8 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.5 |
0.9 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.5 |
1.4 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.5 |
0.9 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.5 |
1.4 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.5 |
9.6 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.5 |
4.6 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.5 |
4.6 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.5 |
2.7 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.5 |
31.4 |
GO:0051436 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
| 0.5 |
0.5 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.5 |
31.8 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.5 |
8.2 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.5 |
0.5 |
GO:0060353 |
regulation of cell adhesion molecule production(GO:0060353) |
| 0.5 |
5.9 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.5 |
1.8 |
GO:0051145 |
smooth muscle cell differentiation(GO:0051145) |
| 0.5 |
3.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.5 |
0.9 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.4 |
4.9 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.4 |
6.3 |
GO:0071897 |
DNA biosynthetic process(GO:0071897) |
| 0.4 |
11.2 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.4 |
0.4 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 |
1.8 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.4 |
6.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.4 |
4.4 |
GO:0010829 |
negative regulation of glucose transport(GO:0010829) |
| 0.4 |
1.8 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.4 |
4.0 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.4 |
1.8 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.4 |
1.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.4 |
5.3 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.4 |
1.3 |
GO:0071549 |
cellular response to dexamethasone stimulus(GO:0071549) |
| 0.4 |
2.2 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.4 |
0.9 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.4 |
0.9 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.4 |
1.8 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.4 |
11.8 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.4 |
2.2 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.4 |
3.1 |
GO:0034670 |
chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.4 |
1.7 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.4 |
8.3 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.4 |
40.5 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.4 |
1.7 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.4 |
0.9 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.4 |
1.3 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.4 |
12.5 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.4 |
1.3 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.4 |
0.9 |
GO:0097466 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.4 |
2.6 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.4 |
0.4 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.4 |
13.7 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.4 |
3.0 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.4 |
7.2 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.4 |
2.5 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.4 |
6.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.4 |
1.3 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.4 |
0.4 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.4 |
2.9 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.4 |
0.8 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.4 |
7.4 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.4 |
1.2 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.4 |
0.4 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.4 |
2.1 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.4 |
3.3 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.4 |
1.2 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.4 |
7.0 |
GO:0036257 |
multivesicular body organization(GO:0036257) |
| 0.4 |
4.1 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.4 |
1.6 |
GO:0021953 |
central nervous system neuron differentiation(GO:0021953) |
| 0.4 |
1.6 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.4 |
3.3 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.4 |
2.0 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.4 |
13.8 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.4 |
2.8 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.4 |
0.4 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.4 |
2.4 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.4 |
2.8 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.4 |
4.4 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.4 |
3.2 |
GO:0002369 |
T cell cytokine production(GO:0002369) |
| 0.4 |
0.8 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.4 |
1.6 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.4 |
1.2 |
GO:0044725 |
chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
| 0.4 |
1.2 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.4 |
4.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.4 |
0.4 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.4 |
1.2 |
GO:0035176 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.4 |
11.3 |
GO:1901224 |
positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.4 |
1.2 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.4 |
1.5 |
GO:1902962 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.4 |
0.8 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.4 |
10.8 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.4 |
1.9 |
GO:0035739 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.4 |
0.8 |
GO:0002254 |
kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.4 |
0.8 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.4 |
4.6 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.4 |
5.4 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.4 |
3.5 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.4 |
3.4 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.4 |
0.4 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.4 |
0.4 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.4 |
3.8 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.4 |
1.1 |
GO:0046946 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.4 |
1.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.4 |
3.0 |
GO:0070987 |
error-free translesion synthesis(GO:0070987) |
| 0.4 |
1.9 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.4 |
1.1 |
GO:0044854 |
plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 0.4 |
3.0 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.4 |
7.8 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.4 |
3.3 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.4 |
1.5 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.4 |
1.9 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.4 |
0.7 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.4 |
3.0 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.4 |
1.5 |
GO:1904044 |
response to aldosterone(GO:1904044) |
| 0.4 |
0.7 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.4 |
0.7 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.4 |
1.5 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.4 |
4.7 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.4 |
0.4 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.4 |
0.7 |
GO:0031062 |
positive regulation of histone methylation(GO:0031062) |
| 0.4 |
1.8 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.4 |
0.7 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.4 |
1.8 |
GO:0030952 |
establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.4 |
3.3 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.4 |
1.1 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.4 |
17.0 |
GO:1902475 |
L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.4 |
1.4 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.4 |
0.4 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.4 |
1.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 |
2.5 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.4 |
11.5 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.4 |
1.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.4 |
10.8 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.4 |
4.7 |
GO:0036376 |
sodium ion export from cell(GO:0036376) |
| 0.4 |
1.1 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.4 |
3.6 |
GO:1901222 |
regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.4 |
5.0 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.4 |
2.1 |
GO:0009099 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.4 |
1.8 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.4 |
6.7 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.4 |
0.7 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.4 |
1.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 |
1.0 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.3 |
12.1 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.3 |
5.2 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.3 |
1.0 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.3 |
1.7 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.3 |
1.0 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.3 |
4.1 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.3 |
2.4 |
GO:0055062 |
phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
| 0.3 |
2.4 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.3 |
9.9 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.3 |
1.7 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.3 |
4.4 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.3 |
2.0 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.3 |
1.0 |
GO:0060318 |
regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
| 0.3 |
0.3 |
GO:0061740 |
protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.3 |
1.0 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.3 |
3.0 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.3 |
0.7 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 0.3 |
1.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 |
1.3 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.3 |
2.3 |
GO:0008595 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.3 |
1.0 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.3 |
0.3 |
GO:0010332 |
response to gamma radiation(GO:0010332) |
| 0.3 |
11.3 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.3 |
0.7 |
GO:0072665 |
protein localization to vacuole(GO:0072665) |
| 0.3 |
4.0 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.3 |
2.0 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 |
1.0 |
GO:0035844 |
cloaca development(GO:0035844) |
| 0.3 |
1.6 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.3 |
1.0 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.3 |
17.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.3 |
1.0 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.3 |
2.9 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.3 |
1.6 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.3 |
0.3 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.3 |
0.6 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.3 |
0.6 |
GO:0052314 |
phytoalexin metabolic process(GO:0052314) |
| 0.3 |
34.3 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.3 |
0.3 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.3 |
1.9 |
GO:0050932 |
regulation of pigment cell differentiation(GO:0050932) |
| 0.3 |
2.5 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 |
0.3 |
GO:0030852 |
regulation of granulocyte differentiation(GO:0030852) |
| 0.3 |
0.6 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.3 |
0.9 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.3 |
1.2 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.3 |
3.7 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.3 |
3.1 |
GO:0048302 |
regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.3 |
1.9 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.3 |
2.2 |
GO:0050482 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.3 |
28.4 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.3 |
0.6 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.3 |
8.6 |
GO:0034204 |
lipid translocation(GO:0034204) |
| 0.3 |
0.6 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.3 |
0.3 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.3 |
1.5 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.3 |
0.6 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.3 |
1.2 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.3 |
0.3 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.3 |
1.5 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 |
1.2 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.3 |
0.9 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.3 |
0.3 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.3 |
8.1 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.3 |
1.2 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.3 |
3.3 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.3 |
2.1 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.3 |
0.6 |
GO:0042262 |
DNA protection(GO:0042262) |
| 0.3 |
0.3 |
GO:0019230 |
proprioception(GO:0019230) |
| 0.3 |
0.3 |
GO:0090270 |
fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.3 |
1.2 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.3 |
1.5 |
GO:0006294 |
nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.3 |
1.5 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 |
0.3 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.3 |
15.8 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.3 |
6.1 |
GO:0033617 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.3 |
13.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.3 |
0.6 |
GO:1905053 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.3 |
2.6 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.3 |
0.6 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.3 |
0.6 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.3 |
3.7 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.3 |
2.3 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.3 |
0.8 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.3 |
2.2 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.3 |
0.6 |
GO:0036022 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.3 |
1.7 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.3 |
0.6 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.3 |
1.9 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.3 |
7.8 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.3 |
1.1 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.3 |
0.3 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.3 |
0.5 |
GO:1900271 |
regulation of long-term synaptic potentiation(GO:1900271) |
| 0.3 |
0.3 |
GO:0006641 |
triglyceride metabolic process(GO:0006641) |
| 0.3 |
1.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.3 |
0.5 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 0.3 |
5.4 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.3 |
2.7 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.3 |
6.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
8.1 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 0.3 |
0.3 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.3 |
1.1 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.3 |
3.0 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.3 |
0.3 |
GO:0051132 |
NK T cell activation(GO:0051132) |
| 0.3 |
0.8 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.3 |
0.3 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.3 |
1.9 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.3 |
1.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 |
19.2 |
GO:0045814 |
negative regulation of gene expression, epigenetic(GO:0045814) |
| 0.3 |
6.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.3 |
5.6 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.3 |
1.1 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.3 |
0.3 |
GO:1901661 |
quinone metabolic process(GO:1901661) |
| 0.3 |
23.7 |
GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.3 |
1.1 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.3 |
2.1 |
GO:0035729 |
cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.3 |
10.8 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.3 |
1.0 |
GO:0000422 |
mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.3 |
1.6 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.3 |
3.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.3 |
2.1 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.3 |
1.0 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 0.3 |
3.9 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.3 |
29.4 |
GO:1902749 |
regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.3 |
0.8 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.3 |
0.3 |
GO:0009648 |
photoperiodism(GO:0009648) |
| 0.3 |
0.5 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.3 |
0.5 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 |
1.0 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.3 |
1.0 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.3 |
0.5 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 0.3 |
0.5 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.3 |
0.5 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
0.7 |
GO:0009120 |
deoxyribonucleoside metabolic process(GO:0009120) |
| 0.2 |
2.5 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.2 |
0.7 |
GO:0048087 |
positive regulation of developmental pigmentation(GO:0048087) |
| 0.2 |
6.5 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.2 |
0.2 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.2 |
1.0 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.2 |
0.7 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 |
3.7 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.2 |
0.2 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.2 |
4.9 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.2 |
2.7 |
GO:0043578 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.2 |
1.5 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.2 |
0.2 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 |
5.8 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 |
2.6 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.2 |
1.2 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.2 |
0.5 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
1.7 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 |
0.5 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.2 |
1.0 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.2 |
1.9 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 |
0.9 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
1.2 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.2 |
1.6 |
GO:0019556 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.2 |
1.9 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.2 |
0.9 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.2 |
0.2 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.2 |
0.2 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.2 |
0.9 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.2 |
5.8 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
| 0.2 |
0.9 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.2 |
3.2 |
GO:0006363 |
transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
| 0.2 |
0.5 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.2 |
0.7 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.2 |
0.7 |
GO:1904616 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.2 |
0.5 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.2 |
0.7 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.2 |
1.1 |
GO:0032960 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.2 |
1.6 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 |
2.1 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.2 |
0.2 |
GO:0033025 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.2 |
2.0 |
GO:0043382 |
positive regulation of memory T cell differentiation(GO:0043382) |
| 0.2 |
14.4 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 |
2.0 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 |
13.0 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.2 |
0.4 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.2 |
2.4 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.2 |
0.4 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.2 |
0.4 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.2 |
0.4 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.2 |
4.2 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.2 |
1.5 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.2 |
1.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.2 |
6.3 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 |
7.3 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.2 |
1.1 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.2 |
5.4 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.2 |
1.7 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.2 |
0.4 |
GO:1904253 |
positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.2 |
2.8 |
GO:0055092 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.2 |
2.6 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 |
0.4 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.2 |
2.7 |
GO:2000674 |
regulation of type B pancreatic cell apoptotic process(GO:2000674) |
| 0.2 |
2.9 |
GO:0043981 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
0.2 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.2 |
1.9 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.2 |
1.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.2 |
1.0 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.2 |
2.9 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.2 |
2.5 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.2 |
2.9 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 |
6.2 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 |
1.6 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.2 |
0.8 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.2 |
2.0 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.2 |
1.8 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
2.0 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.2 |
4.9 |
GO:0000819 |
sister chromatid segregation(GO:0000819) |
| 0.2 |
0.2 |
GO:0010907 |
positive regulation of glucose metabolic process(GO:0010907) |
| 0.2 |
1.0 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 |
1.0 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.2 |
2.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
4.0 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.2 |
0.6 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.2 |
1.6 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.2 |
0.2 |
GO:0001519 |
peptide amidation(GO:0001519) peptide modification(GO:0031179) |
| 0.2 |
1.6 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.2 |
1.2 |
GO:0032905 |
transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
| 0.2 |
0.6 |
GO:1904181 |
positive regulation of membrane depolarization(GO:1904181) |
| 0.2 |
0.2 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.2 |
3.3 |
GO:1901018 |
positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
| 0.2 |
2.5 |
GO:0030183 |
B cell differentiation(GO:0030183) |
| 0.2 |
2.9 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.2 |
3.1 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.2 |
1.1 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.2 |
0.2 |
GO:0021831 |
embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.2 |
1.5 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.2 |
4.4 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.2 |
0.8 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.2 |
1.1 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
1.5 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.2 |
0.9 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.2 |
0.8 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.2 |
3.0 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.2 |
5.6 |
GO:0032608 |
interferon-beta production(GO:0032608) |
| 0.2 |
6.4 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.2 |
1.5 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.2 |
2.2 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.2 |
1.3 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.2 |
0.4 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.2 |
1.3 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.2 |
0.2 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.2 |
1.1 |
GO:0032324 |
molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.2 |
0.2 |
GO:0032930 |
positive regulation of superoxide anion generation(GO:0032930) |
| 0.2 |
7.5 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.2 |
1.6 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
3.3 |
GO:0030890 |
positive regulation of B cell proliferation(GO:0030890) |
| 0.2 |
1.8 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.2 |
0.5 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.2 |
0.5 |
GO:0044803 |
multi-organism membrane organization(GO:0044803) |
| 0.2 |
0.4 |
GO:0032817 |
regulation of natural killer cell proliferation(GO:0032817) |
| 0.2 |
1.6 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.2 |
0.5 |
GO:0045212 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.2 |
0.7 |
GO:1901725 |
regulation of histone deacetylase activity(GO:1901725) |
| 0.2 |
2.0 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
0.2 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.2 |
0.9 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.2 |
2.8 |
GO:0006739 |
NADP metabolic process(GO:0006739) |
| 0.2 |
4.0 |
GO:0048490 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 |
0.5 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.2 |
1.1 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.2 |
0.7 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.2 |
0.3 |
GO:0010536 |
positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.2 |
0.3 |
GO:0060295 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.2 |
1.2 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
0.2 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.2 |
1.9 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.2 |
6.2 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 |
2.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
0.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.2 |
0.3 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.2 |
1.4 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.2 |
4.0 |
GO:0055072 |
iron ion homeostasis(GO:0055072) |
| 0.2 |
2.2 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.2 |
1.8 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.2 |
3.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.2 |
0.2 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
| 0.2 |
0.5 |
GO:0033320 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.2 |
0.7 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.2 |
0.3 |
GO:0051344 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 |
3.5 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.2 |
1.2 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.2 |
1.0 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.2 |
1.1 |
GO:0070423 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.2 |
0.8 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 |
0.8 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 |
2.9 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.2 |
0.5 |
GO:0014743 |
regulation of muscle hypertrophy(GO:0014743) |
| 0.2 |
26.0 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.2 |
0.5 |
GO:0034197 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 |
0.2 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.2 |
0.5 |
GO:0043038 |
amino acid activation(GO:0043038) |
| 0.2 |
9.1 |
GO:0000086 |
G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.2 |
1.3 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 |
0.8 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 |
2.2 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.2 |
0.3 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.2 |
1.7 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.2 |
3.4 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.2 |
5.4 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.2 |
1.4 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.2 |
6.4 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.1 |
GO:2000779 |
regulation of double-strand break repair(GO:2000779) |
| 0.1 |
2.1 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.1 |
GO:0009445 |
putrescine metabolic process(GO:0009445) |
| 0.1 |
3.0 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
2.1 |
GO:2000651 |
positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.1 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.1 |
0.4 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.1 |
0.1 |
GO:0009415 |
response to water(GO:0009415) |
| 0.1 |
1.6 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.4 |
GO:0001832 |
blastocyst growth(GO:0001832) inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
2.7 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 |
1.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.4 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.1 |
2.3 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 |
0.8 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
0.6 |
GO:0031054 |
pre-miRNA processing(GO:0031054) |
| 0.1 |
0.1 |
GO:0002874 |
regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.1 |
1.0 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.8 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.1 |
0.8 |
GO:0001736 |
establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
| 0.1 |
1.2 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.1 |
2.6 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.4 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
4.1 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.5 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.4 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.9 |
GO:0070670 |
response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
| 0.1 |
1.3 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.1 |
0.3 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.1 |
0.1 |
GO:0051928 |
positive regulation of calcium ion transport(GO:0051928) |
| 0.1 |
0.5 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.1 |
1.9 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.1 |
0.8 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.1 |
0.3 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.1 |
0.3 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.7 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.9 |
GO:0090154 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.4 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.1 |
0.1 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
0.9 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.1 |
1.4 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.1 |
0.6 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.1 |
0.9 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.3 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.1 |
0.4 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 |
5.0 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.3 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.1 |
0.9 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
6.4 |
GO:0006094 |
gluconeogenesis(GO:0006094) |
| 0.1 |
0.1 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.1 |
0.7 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.1 |
0.5 |
GO:0016062 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.1 |
0.4 |
GO:0031929 |
TOR signaling(GO:0031929) |
| 0.1 |
0.1 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.2 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 |
0.4 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.4 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.1 |
0.7 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 |
0.3 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.6 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 |
0.7 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.1 |
0.6 |
GO:1904427 |
positive regulation of calcium ion transmembrane transport(GO:1904427) |
| 0.1 |
2.6 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.1 |
1.1 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
3.0 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 |
0.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.9 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
1.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.2 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.3 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
2.0 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
0.7 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.1 |
2.2 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.3 |
GO:0032042 |
mitochondrial DNA metabolic process(GO:0032042) |
| 0.1 |
1.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.1 |
1.1 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.1 |
1.4 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.1 |
0.2 |
GO:0033077 |
T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.1 |
0.4 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 |
0.6 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
0.1 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 |
0.9 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
6.5 |
GO:1990830 |
response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.1 |
0.2 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.1 |
0.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.1 |
0.3 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.1 |
0.4 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 |
3.2 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
1.4 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.1 |
0.3 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.1 |
1.8 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.5 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.1 |
3.2 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.1 |
0.2 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.3 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.2 |
GO:2001190 |
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.1 |
0.1 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.5 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.1 |
0.9 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.1 |
3.9 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
0.3 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
0.7 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.1 |
3.0 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.4 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.9 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 |
1.8 |
GO:0098719 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.1 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
0.5 |
GO:0010714 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 |
1.6 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 |
3.9 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
2.4 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 |
0.4 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
| 0.1 |
0.7 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.1 |
0.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.1 |
GO:0090312 |
positive regulation of protein deacetylation(GO:0090312) |
| 0.1 |
0.4 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
1.3 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
1.4 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.1 |
1.4 |
GO:1903670 |
regulation of sprouting angiogenesis(GO:1903670) |
| 0.1 |
1.1 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.1 |
GO:0014061 |
regulation of norepinephrine secretion(GO:0014061) |
| 0.1 |
3.4 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
0.3 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.1 |
0.2 |
GO:1903980 |
positive regulation of microglial cell activation(GO:1903980) |
| 0.1 |
0.4 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.1 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 |
3.6 |
GO:0046323 |
glucose import(GO:0046323) |
| 0.1 |
0.6 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
0.5 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 0.1 |
0.5 |
GO:1903027 |
regulation of opsonization(GO:1903027) |
| 0.1 |
0.2 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.1 |
0.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.5 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.1 |
0.2 |
GO:0045575 |
basophil activation(GO:0045575) |
| 0.1 |
2.2 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.1 |
1.0 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.1 |
0.5 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) |
| 0.1 |
0.1 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.1 |
0.4 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.4 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.6 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.1 |
0.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
1.3 |
GO:0051058 |
negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.2 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.1 |
0.3 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.1 |
1.4 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.1 |
1.0 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.1 |
0.3 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 |
0.1 |
GO:0002313 |
mature B cell differentiation involved in immune response(GO:0002313) |
| 0.1 |
0.4 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.1 |
0.1 |
GO:1902222 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 |
0.1 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.1 |
0.1 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.2 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.1 |
0.7 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 |
0.2 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 |
0.2 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
0.1 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.1 |
0.1 |
GO:0061525 |
hindgut development(GO:0061525) |
| 0.1 |
0.2 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
0.2 |
GO:0042348 |
regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.1 |
3.1 |
GO:0002223 |
stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.1 |
0.5 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.1 |
0.4 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.1 |
0.1 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
0.2 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.1 |
0.1 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.1 |
0.2 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.1 |
0.4 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.1 |
0.1 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
0.7 |
GO:0042953 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
0.3 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.4 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.1 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.1 |
0.3 |
GO:0055012 |
ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.1 |
0.1 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.1 |
0.3 |
GO:0046373 |
arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 |
0.1 |
GO:1902232 |
regulation of positive thymic T cell selection(GO:1902232) |
| 0.1 |
0.1 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.1 |
1.0 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.3 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
2.5 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.1 |
0.3 |
GO:0044065 |
regulation of respiratory system process(GO:0044065) |
| 0.0 |
0.2 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.0 |
0.1 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.0 |
0.0 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.0 |
0.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.0 |
0.1 |
GO:0006778 |
porphyrin-containing compound metabolic process(GO:0006778) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
2.9 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.1 |
GO:0032530 |
regulation of microvillus organization(GO:0032530) |
| 0.0 |
0.4 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
0.1 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
0.8 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.1 |
GO:0071380 |
cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.0 |
0.4 |
GO:0097398 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 |
0.4 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
0.7 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.6 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.4 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.0 |
0.0 |
GO:2000399 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.0 |
0.2 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 |
0.1 |
GO:0002545 |
chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.0 |
0.3 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.0 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.0 |
0.2 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.0 |
0.2 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.0 |
0.3 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.0 |
0.1 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.0 |
1.1 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
| 0.0 |
0.1 |
GO:0021793 |
chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.0 |
0.1 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.0 |
0.1 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.0 |
0.3 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.0 |
GO:0030218 |
erythrocyte differentiation(GO:0030218) |
| 0.0 |
0.9 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.0 |
0.7 |
GO:0030818 |
negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.0 |
0.3 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.1 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 |
0.1 |
GO:2000484 |
positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.0 |
0.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.0 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
1.1 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.0 |
0.1 |
GO:0060964 |
regulation of gene silencing by miRNA(GO:0060964) |
| 0.0 |
0.2 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.0 |
0.1 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.0 |
0.1 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.0 |
0.2 |
GO:0006929 |
substrate-dependent cell migration(GO:0006929) |
| 0.0 |
4.4 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.0 |
0.2 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.4 |
GO:0075733 |
intracellular transport of virus(GO:0075733) |
| 0.0 |
0.5 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.3 |
GO:0006032 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.1 |
GO:0048864 |
stem cell development(GO:0048864) |
| 0.0 |
0.4 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.0 |
0.1 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.0 |
0.1 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.1 |
GO:0046877 |
regulation of saliva secretion(GO:0046877) |
| 0.0 |
0.2 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.2 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.3 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.1 |
GO:0038112 |
interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.0 |
0.1 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.0 |
0.0 |
GO:0045714 |
regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.0 |
0.0 |
GO:0060969 |
negative regulation of gene silencing(GO:0060969) |
| 0.0 |
0.0 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.0 |
0.1 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
4.3 |
GO:0016567 |
protein ubiquitination(GO:0016567) |
| 0.0 |
0.1 |
GO:0006089 |
lactate metabolic process(GO:0006089) |